• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙库巴曲缬沙坦通过调控 IL6/STAT1 通路对诱导的肠缺血/再灌注损伤的保护作用。

Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway.

机构信息

Department of Pharmacology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.

Department of Histology and Cell Biology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.

出版信息

J Pharm Pharmacol. 2024 Jul 5;76(7):788-797. doi: 10.1093/jpp/rgae031.

DOI:10.1093/jpp/rgae031
PMID:38538077
Abstract

OBJECTIVES

Intestinal ischemia reperfusion (IIR) is a critical emergency situation that needs immediate intervention. Small intestine is one of the most sensitive tissues to IR injury and it remains a highly morbid condition, with reported mortality rates ranging from 30% to 90%. Thus, we aimed to evaluate the suspected protective role of sacubitril/valsartan (SAC/VAL) on IIR injury.

METHODS

Thirty-two adult male Wistar rats were used in our model and divided into four groups: sham group, SAC/VAL treated group without IIR, IIR group, and SAC/VAL treated group with IIR. SAC/VAL in a dose of 30 mg/kg was administered orally just before induction of IIR.

KEY FINDINGS

SAC/VAL significantly ameliorated IIR-induced changes as it decreased malondialdehyde (MDA), tumor necrosis factor alpha (TNFα), angiotensin II (ANG II), interleukin 6 (IL 6), active caspase 3, and signal transducer- and activator-of transcription (STAT1). However, SAC/VAL administration significantly increased antioxidant parameters such as total antioxidant capacity (TAC), superoxide dismutase (SOD), and reduced glutathione (GSH). Moreover, alteration of the histological structure was observed in IIR group that was improved by SAC/VAL.

CONCLUSIONS

SAC/VAL prevents IIR-induced damage via modulation of renin angiotensin aldosterone system, antioxidant, anti-apoptotic, anti-inflammatory properties, and regulation of IL6/STAT1 pathway.

摘要

目的

肠缺血再灌注(IIR)是一种需要立即干预的危急情况。小肠是对 IR 损伤最敏感的组织之一,它仍然是一种高度病态的情况,报告的死亡率范围为 30%至 90%。因此,我们旨在评估沙库巴曲缬沙坦(SAC/VAL)对 IIR 损伤的可疑保护作用。

方法

我们的模型使用了 32 只成年雄性 Wistar 大鼠,并将其分为四组:假手术组、未发生 IIR 的 SAC/VAL 治疗组、发生 IIR 的 IIR 组和发生 IIR 的 SAC/VAL 治疗组。在诱导 IIR 之前,以 30mg/kg 的剂量口服给予 SAC/VAL。

主要发现

SAC/VAL 显著改善了 IIR 诱导的变化,因为它降低了丙二醛(MDA)、肿瘤坏死因子-α(TNFα)、血管紧张素 II(ANG II)、白细胞介素 6(IL 6)、活性半胱氨酸天冬氨酸蛋白酶 3 和信号转导和转录激活因子 1(STAT1)。然而,SAC/VAL 给药显著增加了抗氧化参数,如总抗氧化能力(TAC)、超氧化物歧化酶(SOD)和还原型谷胱甘肽(GSH)。此外,在 IIR 组中观察到组织学结构的改变,SAC/VAL 改善了这种改变。

结论

SAC/VAL 通过调节肾素-血管紧张素-醛固酮系统、抗氧化、抗凋亡、抗炎特性以及调节 IL6/STAT1 通路,防止 IIR 诱导的损伤。

相似文献

1
Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway.沙库巴曲缬沙坦通过调控 IL6/STAT1 通路对诱导的肠缺血/再灌注损伤的保护作用。
J Pharm Pharmacol. 2024 Jul 5;76(7):788-797. doi: 10.1093/jpp/rgae031.
2
Sacubitril/valsartan alleviates sepsis-induced myocardial injury in rats via dual angiotensin receptor-neprilysin inhibition and modulation of inflammasome/caspase 1/IL1β pathway.沙库巴曲缬沙坦通过双重血管紧张素受体-脑啡肽酶抑制和调控炎症小体/半胱天冬酶 1/IL1β 通路减轻大鼠脓毒症诱导的心肌损伤。
Eur J Pharmacol. 2024 Sep 15;979:176834. doi: 10.1016/j.ejphar.2024.176834. Epub 2024 Jul 20.
3
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.联合左西孟旦和沙库巴曲缬沙坦显著保护心脏和肾脏免受大鼠心肾综合征的影响。
Biomed Pharmacother. 2022 Apr;148:112745. doi: 10.1016/j.biopha.2022.112745. Epub 2022 Feb 21.
4
Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats.沙库巴曲缬沙坦通过改善 Wistar 大鼠的氧化损伤保护实验性心肌梗死。
Clin Exp Hypertens. 2019;41(1):62-69. doi: 10.1080/10641963.2018.1441862. Epub 2018 Mar 29.
5
Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in mice and KKAy mice compared with valsartan treatment.沙库巴曲缬沙坦治疗与缬沙坦治疗相比,在调节糖尿病肾病方面对小鼠和 KKAy 小鼠有不同的影响。
Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1133-F1151. doi: 10.1152/ajprenal.00614.2020. Epub 2021 Apr 19.
6
Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system.沙库巴曲缬沙坦对持续光照诱导和乳清酸诱导的高血压心脏的影响:与肾素-血管紧张素-醛固酮系统的相互作用。
Biomed Pharmacother. 2024 Apr;173:116391. doi: 10.1016/j.biopha.2024.116391. Epub 2024 Mar 11.
7
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.沙库巴曲缬沙坦通过抑制心室血管僵硬度抑制肥胖相关舒张功能障碍。
Cardiovasc Diabetol. 2021 Apr 21;20(1):80. doi: 10.1186/s12933-021-01270-1.
8
Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury.甲基丁香酚减轻肠缺血/再灌注损伤的机制。
Appl Physiol Nutr Metab. 2017 Oct;42(10):1097-1105. doi: 10.1139/apnm-2017-0043. Epub 2017 Jun 26.
9
Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway.沙库巴曲缬沙坦通过干扰氧化应激、炎症和 Caspase 3 凋亡途径减轻预处理小鼠模型中多柔比星诱导的心脏毒性。
Anatol J Cardiol. 2021 Nov;25(11):821-828. doi: 10.5152/AnatolJCardiol.2021.356.
10
Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.沙库巴曲缬沙坦通过改善自发性高血压大鼠心房重构降低心房颤动易感性。
Eur J Pharmacol. 2023 Aug 5;952:175754. doi: 10.1016/j.ejphar.2023.175754. Epub 2023 May 12.